DOSAGE OF SOMATOSTATIN

Dec 23, 11
Other articles:
  • IV 250 mcg as a bolus inj, then infuse at 3.5 mcg/kg/hr until bleeding has ceased.
  • The effects of somatostatin were predominantly excitatory, but they varied and
  • Apr 27, 2004 . Then, a constant dose (2.5 yg/kg-hr) of somatostatin (Serono) was added to the
  • level was noticed since the second day of somatostatin administration. An
  • The use of higher doses of somatostatin analogues or the development of new
  • BioInfoBank Library :: Somatostatin :: administration & dosage :: Preclinical
  • The effect was dose dependent but maximal at a secretin infusion of. 0-80 CU.
  • ment the dose-dependenteffects of somatostatin on certain biologic events.2-4
  • Assuming a dose-dependent antiproliferative effect of somatostatin analogues,
  • Mimics the action of naturally occuring somatostatin and decreases the secretion
  • Dosage information. What are the dosage forms somatostatin is available in the
  • Dec 28, 1982 . Suitable dosages of somatostatin are 1 μg to 10 mg/kg of body weight. Preferred
  • Short-term estradiol replacement in postmenopausal women selectively mutes
  • Dosage information for patients with specific tumors follows. . . Limited published
  • Publication » Safety review: Dose optimization of somatostatin analogs in
  • by local production of eendorphin from lymphocytes ob- tained from popliteal
  • A comparison of two different dosages of somatostatin combined with
  • The optimal dosage of somatostatin analogs for the long-term control of carcinoid
  • OBJECTIVES: High dose of somatostatin infusion achieves a greater reduction of
  • sufficiently and the dosage of somatostatin was doubled. The drainage material
  • Conclusion: Somatostatin at a dose of 150 /g every. 8 hours is well tolerated and
  • Octreotide is an octapeptide analogue of somatostatin with a longer half-life but
  • Using radiolabeled microspheres, spinal cord blood flow was measured after
  • Octreotide acetate injection is available as: sterile 5 mL multi-dose vials in 2 .
  • was treated with a somatostatin analogue, given at a dose of 100 pg
  • Objective: High-dose somatostatin analogue treatment has shown an
  • Mar 26, 2008 . Study arm 2: usual dosage of a somatostatin analog Study arm 1: half dosage of
  • Eumedica Somatostatin(somatostatin): Treatment of intestinal & pancreatic
  • and dose of treatment (P < 0.05). However . even when, in a long-term study, the
  • Somatostatin Lyomark(somatostatin): Severe acute haemorrhage from gastric or
  • A Single-Dose Comparison of the Acute Effects between the New Somatostatin
  • Effect of high doses of somatostatin on adenylate cyclase activity in peripheral
  • proliferative effect of somatostatin and its analogs on cancer cell lines than on
  • The effect of low dose infusions of somatostatin on meal stimulated gastric acid
  • A comparison of two different dosages of somatostatin combined with
  • and subsequent sclerotherapy is important for the success of the management.
  • Somatostatin was started at 3.5 µg/(kg h) and increased every day to a maximal
  • Short-term estradiol replacement in postmenopausal women selectively mutes
  • Effects of graded doses of somatostatin on gallbladder emptying and pancreatic
  • Jul 15, 2003 . What is the role of somatostatin in the management of esophageal variceal
  • Subcutaneous administration produces very low blood levels of somatostatin.
  • The optimal dosage of somatostatin analogs for the long-term control of carcinoid
  • During preclinical studies in the rabbit, somatostatin doses of 0.2 mg/kg/day and
  • The actions of progressive doses of intraperitoneally (IP) administered
  • Stool volume, frequency, fat content,. Figure 1: Composite histogram showing
  • and large doses on behavior and motor control. Can. J. Physisl. J'harmacol. 55,
  • Basal and 2-deoxy-D-glucose-induced gastric acid secretion was also
  • Dec 11, 2010 . Dosage of Somatostatin (Growth hormone-inhibiting hormone). In Acute bleeding
  • Somatostatin See Introduction, Dosage. Somatostatin 's dosage details are as
  • (2005) Villanueva et al. American Journal of Gastroenterology. Read by

  • Sitemap